Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.

World journal of gastroenterology - 21 May 2016

Joo Moon Kyung, Park Jong-Jae, Chun Hoon Jai

Abstract excerpt

Signaling pathways of gastric carcinogenesis and gastric cancer progression are being avidly studied to seek optimal treatment of gastric cancer. Among them, hepatocyte growth factor (HGF)/c-MET, phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) and janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) pathways have been widely investigated. Their aberrant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Patient Selection

Share to Precision Medicine

Share to Predictive Value of Tests

Share to Stomach Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 27217696
DOI: 10.3748/wjg.v22.i19.4638
PMCID: PMC4870071

Genes

STAT3
HGF
MET
JAK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.PMID 27217696Read ↗

Signaling pathways and therapeutic interventions in gastric cancerSemantic proximity Read ↗

Molecular Diagnosis for Personalized Target Therapy in Gastric CancerSemantic proximity Read ↗

Current treatment and recent progress in gastric cancer.Semantic proximity Read ↗

Current and emerging therapies in unresectable and recurrent gastric cancer.Semantic proximity Read ↗

Gastric biomarkers: a global reviewSemantic proximity Read ↗

Induction, growth, drug resistance, and metastasis: A comprehensive summary of the relationship between STAT3 and gastric cancerSemantic proximity Read ↗

The JAK/STAT signaling cascade in gastric carcinoma (Review)Semantic proximity Read ↗

Advanced gastric cancer: Current treatment landscape and future perspectives.Semantic proximity Read ↗

Identifying therapeutic targets in gastric cancer: the current status and future direction.Semantic proximity Read ↗

Targeting the Phosphatidylinositol-3-kinase Pathway in Gastric Cancer: Can Omics Improve Outcomes?Semantic proximity Read ↗

New advances in targeted gastric cancer treatmentSemantic proximity Read ↗

Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.